Mizoribine
CAS: 50924-49-7
Ref. TM-T1188
| 10mg | 49.00 € | ||
| 25mg | 66.00 € | ||
| 50mg | 94.00 € | ||
| 100mg | 161.00 € | ||
| 200mg | 202.00 € | ||
| 1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Product Information
Name:
Mizoribine
Synonyms:
- NSC 289637
- HE 69
- Bredinin
- 1H-Imidazole-4-carboxamide, 5-hydroxy-1-beta-D-ribofuranosyl-
- 1H-Imidazole-4-carboxamide, 5-hydroxy-1-β-<span class="text-smallcaps">D</span>-ribofuranosyl-
- 4-Carbamoyl-1-beta-D-ribofuranosyl-imidazolium-5-olate
- 5-Hydroxy-1-beta-D-ribofuranosyl-1H-imidazole-4-carboxamide
- 5-Hydroxy-1-beta-D-ribofuranosylimidazole-4-carboxamide
- 5-Hydroxy-1-β-<span class="text-smallcaps">D</span>-ribofuranosyl-1H-imidazole-4-carboxamide
- 5-hydroxy-1-pentofuranosyl-1H-imidazole-4-carboxamide
- See more synonyms
- Anhydro-4-carbamoyl-5-hydroxy-1-beta-D-ribofuranosyl-imidazolium hydroxide
- Bredinine
- Brn 4151713
- He-69
- MZR
- Mizoribina
- Mizoribina [INN-Spanish]
- Mizoribinum
- Unii-4Jr41A10Vp
- β-Bredinin
- 1H-Imidazole-4-carboxamide, 5-hydroxy-1-β-D-ribofuranosyl-
- 5-Hydroxy-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide
Description:
Mizoribine (NSC-289637) belongs to the family of 1-Ribosyl-imidazolecarboxamides. Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
259.22
Formula:
C9H13N3O6
Purity:
98.38% - 99.98%
Color/Form:
White To Off-White Crystalline Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T1188 Mizoribine
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
